Active Shortage Injection Oncology
Carboplatin Injection · 1,232 days since initial FDA posting
Brand: CARBOPLATIN
FDA lists Carboplatin Injection as Active Shortage (Teyro Labs).
Availability on file: Unavailable
Carboplatin Injection: Active Shortage
Unavailable Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Carboplatin Injection
- Manufacturer
- Teyro Labs
- Dosage Form
- Injection
- Presentation
- Carboplatin, Injection, 150 mg/15 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-3)
- Package NDC
- 60505-6282-3
Status & Timeline
- Status
- Active Shortage
- Availability
- Unavailable
- First Reported
- Apr 28, 2023
- Last Updated
- Mar 17, 2026
- Therapeutic Category
- Oncology
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Discontinuation of the manufacture of the drug.
Nearby, Other Carboplatin Shortage Records
Carboplatin Injection
Gland Pharma Limited
Injection
Carboplatin Injection
Gland Pharma Limited
Injection
Carboplatin Injection
Gland Pharma Limited
Injection
Carboplatin Injection
Gland Pharma Limited
Injection
Carboplatin Injection
Teyro Labs
Injection
Carboplatin Injection
Teyro Labs
Injection
FDA reason on file: Discontinuation of the manufacture of the drug. General shortage guidance lives on the tracker hub.